Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,545.5
-13.6 (-0.53%)

 

  • STI Straits Times Index
    2,545.5
    -13.6 (-0.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,578.1
    -10.4 (-0.66%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,531.6
    -399.0 (-1.60%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,354.0
    -32.4 (-0.96%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,329.9
    -88.2 (-0.39%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,143.9
    -34.4 (-0.66%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,268.2M
  • Value: 1,358.8M
  • Rise: 113
  • Fall: 217
  • Unch: 478

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.008+0.001
ThaiBev0.605-0.020
Genting Sing0.680-0.030
Asian Healthcare0.285+0.050
Vicplas Intl0.390+0.065
ISDN0.395+0.030
AsiaMedic0.023+0.002
CNMC Goldmine0.360+0.015
Rex Intl0.184-0.003
Medtecs Intl0.970-0.030

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CT ENTERPRISE CT ENTERPRISE
Quotes 15 Minutes Delayed. Updated at 07 Aug 2020 15:59
Last (HKD): 1.360 Change: - High: 1.360 Remarks: -
Change (%): - Low: 1.360
Open 1.360 Yesterday's Close 1.360
Buy Price 1.250 Sell Price 1.560
Buy Volume ('000) 7.5 Sell Volume ('000) 2.5
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.51428 Trailing EPS (HKD) e 0.43387 NAV (HKD) b 6.4208
PE a 2.644 Trailing PE f 3.135 Price / NAV b 0.2118
Dividend (HKD) d - Cash In Hand (HKD) g 0.9965 Issued & Paid-up Shares c 240,718,000
Dividend Yield (%) d - Price / Cash In Hand g 1.365 Treasury Shares h -
Beta - 75 Daysi 0.173 R-Squared - 75 Days(%)i 0.37 Market Cap (M) 327.376
Beta - 500 Daysi 0.473 R-Squared - 500 Days (%)i 3.94 Enterprise Value (M) 362.736
Piotroski F Score 3 Exchange Code 3839 Par Value ( USD ) 0.10000
52 Weeks Volatility (%) 48.37 6-Month VWAP 1.462 Free Float (%) 26.7
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 29 Jul 2015.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CT ENTERPRISE HKEx 327.376 2.644 3.135 0.2118 -
Industry Biotechnology HKEx 59,190.532 23.183 26.007 6.7609 2.161
Local Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Local Peer WUXI BIO HKEx 228,464.733 198.740 198.739 15.9759 -
Local Peer SINO BIOPHARM HKEx 183,064.220 59.645 60.190 5.2838 0.548
Local Peer BEIGENE HKEx 156,345.400 - - - -
Local Peer GENSCRIPT BIO HKEx 31,551.186 - - 10.5642 -
Local Peer 3SBIO HKEx 23,375.225 21.171 21.171 2.1711 -
Local Peer HAOHAI BIOTEC HKEx 21,606.322 51.391 51.391 3.6734 0.631
Local Peer VIVA BIOTECH HKEx 19,664.148 65.227 63.890 9.6876 0.162
Local Peer ALPHAMAB-B HKEx 15,682.212 - - 5.7792 -
Local Peer ASCENTAGE-B HKEx 8,317.959 - - 8.3508 -
Local Peer FRONTAGE HKEx 7,970.458 55.188 55.190 3.8659 -
Local Peer KINTOR PHARMA-B HKEx 5,851.138 - - 15.8289 -
Other Local Peers LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), ESSEX BIO-TECH (HKEx), UNI-BIO GROUP (HKEx), BIOSINO BIO-TEC (HKEx), REGENT PACIFIC (HKEx), HAO WEN H-NEW (HKEx), HAO WEN H-OLD (HKEx)
Global Peer AMGEN INC NASDAQ 141,474.386 18.041 19.383 13.2728 2.425
Global Peer CSL ASX 124,495.695 46.403 42.977 14.3952 0.967
Global Peer GILEAD SCIENCES INC NASDAQ 86,313.200 16.025 - 4.7577 3.696
Global Peer VERTEX PHARMACEUTICAL NASDAQ 71,196.050 60.499 34.216 9.4685 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 66,091.756 31.237 33.506 - -
Global Peer ILLUMINA INC NASDAQ 58,701.510 58.584 62.316 12.6648 -
Global Peer BIOGEN INC NASDAQ 43,957.188 7.465 7.417 3.8870 -
Global Peer MODERNA INC NASDAQ 28,679.658 - - - -
Global Peer SEATTLE GENETICS INC NASDAQ 28,152.715 - - 15.5190 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,772.075 9.471 26.914 2.1707 -
Other Global Peers BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), Lonza (SGX), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), ALKERMES PLC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), FATE THERAPEUTICS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIELA BIO INC (NASDAQ), VERACYTE INC (NASDAQ), UNIQURE N.V. (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), VAXCYTE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), MACROGENICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CYTOKINETICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), HERON THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), COMPUGEN (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), EPIZYME INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), CORTEXYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ALECTOR INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), ARVINAS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), ESPERION THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), TRANSLATE BIO INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), RETROPHIN INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), PRECIGEN INC (NASDAQ), NKARTA INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), OMEROS CORP (NASDAQ), MORPHIC HOLDING INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), IMMUNOGEN INC (NASDAQ), PASSAGE BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VAXART INC (NASDAQ), AKOUOS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NYSE), AVROBIO INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AGENUS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), GERON CORP (NASDAQ), ATHERSYS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ARDELYX INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), DPHARMA (Bursa), ANAPTYSBIO INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), XBIOTECH INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), KAMADA (NASDAQ), MERUS B V (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), IBIO INC (NYSE American), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), IVERIC BIO INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMV INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CABALETTA BIO INC (NASDAQ),